Adversarial Threshold Neural Computer for Molecular de Novo Design-Reference-Cited by-同舟云学术

Adversarial Threshold Neural Computer for Molecular de Novo Design

Published:2018-03-23 Issue:10 Volume:15 Page:4386-4397
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Putin Evgeny¹²,Asadulaev Arip²,Vanhaelen Quentin¹^ORCID,Ivanenkov Yan¹³⁴,Aladinskaya Anastasia V.¹³,Aliper Alex¹,Zhavoronkov Alex¹⁵^ORCID

Affiliation:

1. Pharma.AI Department, Insilico Medicine, Inc., Baltimore, Maryland 21218, United States

2. Computer Technologies Lab, ITMO University, St. Petersburg 197101, Russia

3. Moscow Institute of Physics and Technology (State University), 9 Institutskiy Lane, Dolgoprudny City, Moscow Region 141700, Russian Federation

4. Institute of Biochemistry and Genetics Russian Academy of Science (IBG RAS) Ufa Scientific Centre, Oktyabrya Prospekt 71, 450054 Ufa, Russian Federation

5. The Biogerontology Research Foundation, OX1 1RU Oxford, U.K.

Funder

Russian Science Foundation

Ministry of Education and Science of the Russian Federation

Government of Russian Federation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.7b01137

Reference79 articles.

1. How to improve R&D productivity: the pharmaceutical industry's grand challenge

2. Innovation in the pharmaceutical industry: New estimates of R&D costs

3. Principles of early drug discovery

4. Pursuing the leadlikeness concept in pharmaceutical research

5. Detecting and overcoming systematic bias in high-throughput screening technologies: a comprehensive review of practical issues and methodological solutions

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CardioGenAI: A Machine Learning-Based Framework for Re-Engineering Drugs for Reduced hERG Liability;2024-09-10

2. A comprehensive review of artificial intelligence for pharmacology research;Frontiers in Genetics;2024-09-03

3. Navigating the frontier of drug-like chemical space with cutting-edge generative AI models;Drug Discovery Today;2024-09

4. Deep learning, deconvolutional neural network inverse design of strut-based lattice metamaterials;Computational Materials Science;2024-09

5. Application of artificial intelligence in drug design: A review;Computers in Biology and Medicine;2024-09